Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (135)	3/28/2002 7:47:30 PM
From: mopgcw	Read Replies (1) of 598

Tularik to Present at Banc of America Securities Healthcare Conference BusinessWire, Thursday, March 28, 2002 at 07:01 SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--March 28, 2002--Tularik Inc. (Nasdaq:TLRK) announced that it will be presenting at the Banc of America Securities Healthcare Conference on Wednesday, April 3, 2002 at 8:20 a.m. (PST) at The Four Seasons Hotel in Las Vegas. This presentation will be webcast live and may be accessed at the following site: veracast.com. An archived webcast will be available through Friday, April 19, 2002. About Tularik Tularik is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform spans seven disease-based programs focused on three areas: cancer, immunology and metabolic disease. For more information, visit Tularik's Internet website at www.tularik.com.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next